Kamke Trent G, Senior Vice President of Operations at LeMaitre Vascular (LMAT), has been a consistent seller of company stock over the past year, with no open-market purchases on record. Across 37 total Form 4 filings, all of which relate to LMAT, his transactions show a clear disposition bias: total sell value reached $713,242.18, while buy value stood at zero. The most recent activity reinforces this pattern—three open-market sales occurred between February and May 2026, with the largest single transaction on May 8, 2026, valued at $313,286.92. Earlier sales on March 11 and February 27, 2026, added $284,812.50 and $115,142.76, respectively, bringing the recent three-sale total to roughly $713,000.
The filings also reveal a heavy mix of non-discretionary and compensatory transactions that complicate the raw sell figure. Numerous "A" codes (grants or awards) appear throughout 2025 and 2026, including a cluster of six zero-value grants on June 4, 2026, alongside option exercises ("M") and shares withheld for taxes ("F"). For instance, on March 11, 2026, Kamke exercised options worth $93,135 and immediately sold the underlying shares, while a February 26 exercise was paired with a $10,573.17 tax-withholding transaction. These mechanical events—grants, exercises, and tax withholdings—account for much of the volume, but the open-market sales themselves are discretionary and have been steadily increasing in size, from $115,142.76 in late February to over $313,000 in early May.
The absence of any "P" (purchase) codes across the entire filing history is notable, particularly for an executive with operational oversight. While the grant activity indicates ongoing equity compensation, the consistent conversion of those awards into cash sales—rather than retention—suggests a deliberate strategy of monetizing holdings. The concentration in a single ticker, LMAT, and the accelerating dollar value of recent sales point to a seller who has been actively reducing exposure to the company’s stock throughout the first half of 2026.
AI-assisted summary